Rituximab, but not other biologics, impairs humoral immunity in patients with rheumatoid arthritis—a study using CoVariant protein arrays

OBJECTIVES: RA is an autoimmune disease characterized by chronic inflammation and joint destruction. Biologics are crucial to achieving treat-to-target goals in patients with RA. The global spread and continuous variation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Wei-Hsun, Du, Pin-Xian, Tsai, Pei-Shan, Keskin, Batuhan Birol, Su, Wen-Yu, Lee, Nan-Yao, Ko, Wen-Chien, Lin, Pei-Chun, Shih, Hsi-Chang, Weng, Meng-Yu, Syu, Guan-Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Concise Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627286/
https://www.ncbi.nlm.nih.gov/pubmed/37937178
http://dx.doi.org/10.1093/rap/rkad085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627286/
https://www.ncbi.nlm.nih.gov/pubmed/37937178
http://dx.doi.org/10.1093/rap/rkad085

Ejemplares similares